NTRA News and Press, Natera Inc. From 02/19/20

SAN CARLOS, Calif. , Feb. 19, 2020 /PRNewswire/ --  Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its fourth quarter and year ended December 31, 2019 , after the market close on February 26, 2020...

SAN CARLOS, Calif. , Feb. 18, 2020 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it has filed suit against CareDx for false advertising in the U.S. District Court for Delaware , alleging CareDx used false an...

Cell-free DNA testing services provider Natera ( NTRA -0.2% ) will collaborate with Cambridge, MA-based Elicio Therapeutics on a Phase 1/2 clinical trial evaluating the latter's therapeutic cancer vaccine candidate ELI-002 for the adjuvant treatment of patients with pancreatic ducta...

CAMBRIDGE , Mass. and SAN CARLOS, Calif. , Feb. 11, 2020 /PRNewswire/ --  Elicio Therapeutics , a next generation immuno-oncology company, and Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced their collaboration in a prospective, ...

Signatera test used for patient selection and monitoring to accelerate molecular proof of concept Elicio Therapeutics , a next generation immuno-oncology company, and Natera , Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced their collaboration in a pros...

SAN CARLOS, Calif. , Jan. 27, 2020 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA) a global leader in cell-free DNA testing, filed suit today against ArcherDX for infringement of Natera's U.S. Patent No. 10,538,814 (the "'814 patent"). The complaint was filed in the U.S. District ...

Source: GraycellAdvisors.com Systematic Investing Systematic investing has become a growing part of the stock market. The investing style refers to a rules-based algorithmic system that limits or eliminates individual judgments and biases towards portfolio selection and adjustments. ...

The following slide deck was published by Natera, Inc. in conjunction with this Read more ...

SAN CARLOS, Calif. , Jan. 15, 2020 /PRNewswire/ -- Today Natera, Inc. (NASDAQ: NTRA) announced an agreement with the National Cancer Center (NCC) Japan to launch the CIRCULATE-IDEA trial in Japan , a prospective, multi-center, randomized trial to investigate ctDNA-guided treatment...

SAN CARLOS, Calif. , Jan. 13, 2020 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today filed suit against CareDx for infringing its U.S. Patent 10,526,658 ("the '658 patent"). The U.S. Patent Office most recently recognize...